Difference between revisions of "Template:Cell surface receptor deficiencies"
imported>Arcadian (Exudative vitreoretinopathy) |
imported>Arcadian (Osteopetrosis) |
||
| Line 1: | Line 1: | ||
| − | + | {Navbox | |
|name = Cell surface receptor deficiencies | |name = Cell surface receptor deficiencies | ||
|title = [[Genetic disorder]], membrane: [[cell surface receptor]] deficiencies | |title = [[Genetic disorder]], membrane: [[cell surface receptor]] deficiencies | ||
| Line 55: | Line 55: | ||
| group7 = Lipid receptor | | group7 = Lipid receptor | ||
| − | | list7 = [[Lipoprotein receptor-related protein|LRP]]: ''[[LRP2]]'' ([[Donnai-Barrow syndrome]]){{·}} ''[[Low density lipoprotein receptor-related protein 4|LRP4]]'' ([[Cenani Lenz syndactylism]]){{·}} ''[[LRP5]]'' ([[Worth syndrome]], [[Exudative vitreoretinopathy|Exudative vitreoretinopathy 4]])<BR> | + | | list7 = [[Lipoprotein receptor-related protein|LRP]]: ''[[LRP2]]'' ([[Donnai-Barrow syndrome]]){{·}} ''[[Low density lipoprotein receptor-related protein 4|LRP4]]'' ([[Cenani Lenz syndactylism]]){{·}} ''[[LRP5]]'' ([[Worth syndrome]], [[Exudative vitreoretinopathy|Exudative vitreoretinopathy 4]], [[Osteopetrosis|Osteopetrosis 1]])<BR> |
''[[LDL receptor|LDLR]]'' ([[Familial hypercholesterolemia|LDLR Familial hypercholesterolemia]]) | ''[[LDL receptor|LDLR]]'' ([[Familial hypercholesterolemia|LDLR Familial hypercholesterolemia]]) | ||
Revision as of 23:01, 1 January 2011
{Navbox |name = Cell surface receptor deficiencies |title = Genetic disorder, membrane: cell surface receptor deficiencies |image = |above = | titlestyle = background:Silver
|group2 = G protein-coupled receptor
(including hormone)
|list2 = Template:Navbox subgroup
| group4 = Enzyme-linked receptor
(including
growth factor)
| list4 = Template:Navbox subgroup
| group5 = JAK-STAT
| list5 = Type I cytokine receptor: GH (Laron syndrome) · CSF2RA (Surfactant metabolism dysfunction 4)
MPL (Congenital amegakaryocytic thrombocytopenia)
| group6 = TNF receptor | list6 = TNFRSF1A (TNF receptor associated periodic syndrome) · TNFRSF13B (Selective immunoglobulin A deficiency 2) · TNFRSF5 (Hyper-IgM syndrome type 3) · TNFRSF13C (CVID4) · TNFRSF13B (CVID2) · TNFRSF6 (Autoimmune lymphoproliferative syndrome 1A)
| group7 = Lipid receptor
| list7 = LRP: LRP2 (Donnai-Barrow syndrome) · LRP4 (Cenani Lenz syndactylism) · LRP5 (Worth syndrome, Exudative vitreoretinopathy 4, Osteopetrosis 1)
LDLR (LDLR Familial hypercholesterolemia)
| group10 = Other/ungrouped | list10 = Immunoglobulin superfamily: AGM3, 6
Integrin: LAD 1 · Glanzmann's thrombasthenia · Junctional epidermolysis bullosa with pyloric atresia
EDAR (EDAR Hypohidrotic ectodermal dysplasia) · PTCH1 (Nevoid basal cell carcinoma syndrome) · BMPR1A (BMPR1A Juvenile polyposis syndrome) · IL2RG (X-linked severe combined immunodeficiency)
|below = see also cell surface receptors
Template:Protein defects by function navs
}}